2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$4.75+$0.005 (+0.11%)
Price as of Jul 13, 2026 7:07 PM EDT- $379.3MMarket Cap
- 26.06%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$4.75+$0.005 (+0.11%)
Earnings Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -25.97% | ||
12-Month Momentum | 19.62% | ||
3-Month Risk Adjusted Momentum | -108.70% | ||
12-Month Risk Adjusted Momentum | 40.65% |
True Yield
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 2.67% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -3 |